|
MechanismNicotinic receptors antagonists |
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
A double-blind, placebo-controlled, dose escalation study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of KCP506 in healthy subjects - SAD/MAD study investigating safety, tolerability, PK and PD of KCP506
A double-blind, placebo-controlled, dose escalation study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of KCP506 in healthy subjects
100 Clinical Results associated with Kineta Chronic Pain LLC
0 Patents (Medical) associated with Kineta Chronic Pain LLC
100 Deals associated with Kineta Chronic Pain LLC
100 Translational Medicine associated with Kineta Chronic Pain LLC